925 Chestnut Street
Mezzanine Level
Philadelphia, PA 19107
(215) 955-3607
(215) 503-3976 fax
Mezzanine Level
Philadelphia, PA 19107
(215) 955-3607
(215) 503-3976 fax
Most Recent Peer-reviewed Publications
- The impact of high-density lipoprotein cholesterol levels on long-term outcomes after non-ST-elevation myocardial infarction
- Update on strategies to increase HDL quantity and function.
- Potent and selective PPAR-α agonist LY518674 upregulates both apoA-I production and catabolism in human subjects with the metabolic syndrome
- Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
- Endocannabinoid Antagonism: Blocking the Excess in the Treatment of High-Risk Abdominal Obesity
- Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transport
- High-density lipoprotein cholesterol therapies: The next frontier in lipid management
- Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome
- Drugs in development: Targeting high-density lipoprotein metabolism and reverse cholesterol transport